Brandon Dionne

Brandon Dionne

Auto-generated profile, based on publicly available information

Brandon Dionne

Department of Pharmacy, Brigham and Women's Hospital , Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in CMI Communications
Verified
Journal Article
Open access
JPJeffrey Pearson
Jeffrey Pearson
EGEric Gillett
Eric Gillett
NGNora Danielle Gadri
Nora Danielle Gadri
BDBrandon Dionne
Brandon Dionne

1 September 2019 in Infectious Disease Clinics of North America
Verified
Journal Article
Closed access
BDBrandon Dionne
Brandon Dionne

1 January 2019 in The Journal of Applied Laboratory Medicine
Verified
Journal Article
Closed access
PDF file
MBMaya Beganovic
Maya Beganovic
EMErin K. McCreary
Erin K. McCreary
MMMonica V. Mahoney
Monica V. Mahoney
BDBrandon Dionne
Brandon Dionne
DGDaniel A Green
Daniel A Green
TTTristan Timbrook
Tristan Timbrook
Background: Antimicrobial stewardship programs (ASPs) aim to provide optimal antimicrobial therapy to patients quickly to improve the likelihood of overcoming infection while reducing the risk of adverse effects. Rapid diagnostic tests (RDTs) for infectious diseases have become an integral tool for ASPs to achieve these aims. Content: This review explored the demonstrated clinical value of longer-standing technologies and implications of newer RDTs from an antimicrobial stewardship perspective. Based on available literature, the focus was on the use of RDTs in bloodstream infections (BSIs), particularly those that perform organism identification and genotypic resistance detection, phenotypic susceptibility testing, and direct specimen testing. Clinical implications of rapid testing among respiratory, central nervous system, and gastrointestinal infections are also reviewed. Summary: Coupling RDTs with ASPs facilitates the appropriate and timely use of test results, translating into improved patient outcomes through optimization of antimicrobial use. These benefits are best demonstrated in the use of RDT in BSIs. Rapid phenotypic susceptibility testing offers the potential for early pharmacokinetic/pharmacodynamic optimization, and direct specimen testing on blood may allow ASPs to initiate appropriate therapy and/or tailor empiric therapy even sooner than other RDTs. RDTs for respiratory, central nervous system, and gastrointestinal illnesses have also shown significant promise, although more outcome studies are needed to evaluate their full impact.

1 July 2015 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
BDBrandon Dionne
Brandon Dionne
LNLuke Neff
Luke Neff
SLSamuel A. Lee
Samuel A. Lee
DSDeanna A. Sutton
Deanna A. Sutton
Nathan WiederholdNathan Wiederhold
Nathan Wiederhold
BJBernadette Jakeman
Bernadette Jakeman
Neoscytalidium dimidiatum is a mold known to cause onychomycosis and dermatomycosis; however, it is an extremely rare cause of systemic infection. We report a case of pulmonary infection with Neoscytalidium dimidiatum in an immunocompromised patient and discuss in vitro susceptibility data from this case and previous literature.

1 July 2017 in Surgical Infections
Verified
Journal Article
Closed access
BDBrandon Dionne
Brandon Dionne
WDWalter Dehority
Walter Dehority
MBMeghan Brett
Meghan Brett
THThomas R. Howdieshell
Thomas R. Howdieshell
Background: Splenic injury can occur through multiple mechanisms and may result in various degrees of residual immunocompetence. Functionally or anatomically asplenic patients are at higher risk for infection, particularly with encapsulated bacteria. Vaccination is recommended to prevent infection with these organisms; however, the recommendations are routinely updated, and vaccine selection and timing are complex. Methods: Review of the pertinent English-language literature, including the recommendations of the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. Results: Overwhelming post-splenectomy infection is associated with high morbidity and mortality rates. Patients requiring splenectomy for trauma-related injury appear to be at lower risk for infection than those undergoing splenectomy for a hematologic or oncologic indication. Initial vaccination is dependent on immunization history but generally should consist of the 13-valent pneumococcal conjugate, quadrivalent meningococcal conjugate, meningococcal serogroup B, and Haemophilus influenzae serotype b (Hib) vaccines. Antimicrobial prophylaxis for certain asplenic patients, such as children under the age of five y, may be indicated. Conclusion: Immunization remains a key measure to prevent overwhelming post-splenectomy infection. Consideration of new recommendations and indications, possible interactions, and timing remains important to including optimal response to the vaccines.

21 April 2016 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
BDBrandon Dionne
Brandon Dionne
MBMeghan Brett
Meghan Brett
KCKarissa Culbreath
Karissa Culbreath
RMRenee-Claude Mercier
Renee-Claude Mercier
OBJECTIVE: To evaluate the effect of healthcare worker (HCW) influenza vaccination on the incidence of nosocomial influenzaDESIGN: Retrospective cross-sectional studySETTING: A 550-bed tertiary-care academic medical centerMETHODS: All admitted patients with a direct fluorescent antibody (DFA) or polymerase chain reaction (PCR) assay positive for influenza ordered between October 1 and May 31 from 2010 to 2015 were eligible for inclusion. Nosocomial influenza was defined as a positive influenza test collected ≥48 hours after admission in patients without influenza-like illness present within 24 hours of admission. Relative nosocomial influenza frequency was calculated by dividing the number of nosocomial cases by the total number of admitted patients with influenza for each season. A univariate logistic regression was used to determine the association between HCW influenza vaccination coverage and nosocomial influenza.RESULTS: Over 5 seasons, 533 patients had positive influenza tests during their hospitalization; 29 of these patients (5.4%) acquired influenza during their hospitalization. HCW vaccination coverage increased over the 5 seasons from 47% to 90% (P<.001). Despite an initial decrease in relative nosocomial influenza frequency during the first year (9% to 4.9%), subsequent seasons failed to show an additional decrease in nosocomial infections (4.3%, 5.2%, and 4.8%, respectively); the overall decrease in nosocomial influenza from the first season to the final season was not significant (P=.282). No association was detected between HCW vaccination coverage and nosocomial influenza (odds ratio [OR], 0.990; 95% confidence interval [CI], 0.970–1.011).CONCLUSION: HCW vaccination >50% may not have a significant effect on nosocomial influenza.Infect Control Hosp Epidemiol2016;37:840–844